Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00142168
Status:
TERMINATED
Last Update Posted:
2016-04-21
First Post:
2005-09-01
Brief Title:
CC-5013 Lenalidomide and Rituximab in Waldenstroms Macroglobulinemia
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute